From: EMILIN2 (Elastin microfibril interface located protein), potential modifier of thrombosis
Tissue | Reference |
---|---|
Plasma/serum^ | [36] |
Amniotic fluid^ | [37] |
Seminal plasma^ | [38] |
RA synovial fluid^ | [39] |
Decreased expression in brain arteriovenous malformations* | [40] |
Increased in granulocytes after G-CSF treatment* | [41] |
Increased in mesenchymal stem cells* | [42] |
Osteoblast ECM matrix vesicles^ | [43] |
Decreased in endometrial stromal cells treated with cAMP* | [44] |
Hepatic carcinoma cells* | [45] |
Hepatic carcinoma cells^ | [46] |
Chronic lymphocytic leukemia cells* | [47] |
Colorectal cancer nuclear matrix^ | [48] |
Fragments in sera of patients with ovarian cancer^ | |
Human embryonic stem cell-derived cardiomyocytes^ | [34] |